Clindamycin Hydrochloride Capsule
Category: Anti-Infective
FDA status: To Be Discontinued · Last FDA update: Feb 25, 2026 · First posted: Feb 25, 2026 · 1 manufacturers, 3 listed presentations
As of Feb 25, 2026, the FDA lists Clindamycin Hydrochloride Capsule as being discontinued. Of 3 manufacturer presentations, 3 Not specified.
| Presentation & package NDC | Manufacturer | Availability | FDA note |
|---|---|---|---|
| Cleocin Hydrochloride, Capsule, 75 mg (NDC 0009-0331-02) NDC 0009-0331-02 |
Pfizer Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Cleocin Hydrochloride, Capsule, 150 mg (NDC 0009-0225-02) NDC 0009-0225-02 |
Pfizer Inc. | Not specified | Discontinuation of the manufacture of the drug |
| Cleocin Hydrochloride, Capsule, 300 mg (NDC 0009-0395-14) NDC 0009-0395-14 |
Pfizer Inc. | Not specified | Discontinuation of the manufacture of the drug |
Related medications in shortage
Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.
Change log
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.
Cite this: “FDA drug-shortage status for Clindamycin Hydrochloride Capsule (FDA data as of Feb 25, 2026). Shortage Watch, openFDA.”
Get an email when this record changes
One email, only when the FDA changes something for Clindamycin Hydrochloride Capsule. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.
Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.
Embed a live status badge: /badge/clindamycin-hydrochloride-capsule.svg
FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).